Schott Pharma
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
1SXP | F
Overview
Corporate Details
- ISIN(s):
- DE000A3ENQ51
- LEI:
- 529900TU48UE99NHEY88
- Country:
- Germany
- Address:
- Hattenbergstraße 10, 55122 Mainz
- Website:
- https://www.schott-pharma.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Schott Pharma is a provider of drug containment solutions and delivery systems for the global pharmaceutical and biotech industries. Building on over a century of expertise, the company, formerly a division of Schott AG, became publicly listed in 2023. Its scientifically-proven product portfolio for injectable drugs includes prefillable syringes, cartridges, vials, and ampoules. The company serves pharmaceutical firms, biotechs, and CDMOs by offering solutions ranging from single components to complete systems, ensuring compatibility across the entire value chain from clinical trials to commercialization. It also provides complementary analytical, development, fill-and-finish, and regulatory services, emphasizing quality and innovation to ensure medications are stored and administered safely.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-26 18:40 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.8 KB | ||
| 2025-09-05 00:00 |
Governance Information
2025 September Declarations of Conformity (German)
|
German | 134.6 KB | ||
| 2025-08-18 09:30 |
Report Publication Announcement
|
English | 4.0 KB | ||
| 2025-08-12 07:00 |
Earnings Release
SCHOTT Pharma delivers solid final third-quarter results
|
English | 39.9 KB | ||
| 2025-08-12 00:00 |
Investor Presentation
Presentation 9M 2025
|
English | 1.0 MB | ||
| 2025-08-12 00:00 |
Quarterly Report
Q3 statement / Q3 financial report 2024/2025
|
English | 633.9 KB | ||
| 2025-08-05 09:55 |
Earnings Release
SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 gui…
|
English | 17.6 KB | ||
| 2025-06-11 08:50 |
Board/Management Information
SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appo…
|
English | 12.3 KB | ||
| 2025-06-04 15:30 |
Regulatory News Service
SCHOTT Pharma invests in sterile cartridge production in Hungary
|
English | 8.9 KB | ||
| 2025-05-16 00:00 |
Interim Report
Half-yearly financial report 2024/2025
|
English | 885.8 KB | ||
| 2025-05-15 07:00 |
Earnings Release
SCHOTT Pharma delivers strong second quarter of fiscal year 2025
|
English | 33.6 KB | ||
| 2025-05-15 00:00 |
Investor Presentation
Presentation H1 2025
|
English | 672.0 KB | ||
| 2025-05-06 07:00 |
M&A Activity
SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture…
|
English | 15.0 KB | ||
| 2025-04-11 18:15 |
Earnings Release
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed …
|
English | 5.4 KB | ||
| 2025-04-10 15:58 |
Regulatory News Service
Next expansion milestone achieved: SCHOTT Pharma opens production facility in S…
|
English | 9.6 KB |
Automate Your Workflow. Get a real-time feed of all Schott Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Schott Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
